Trial protocol for COLO‐DETECT: A randomized controlled trial of lesion detection comparing colonoscopy assisted by the GI Genius™ artificial intelligence endoscopy module with standard colonoscopy

Aim Colorectal cancer is the second commonest cause of cancer death worldwide. Colonoscopy plays a key role in the control of colorectal cancer and, in that regard, maximizing detection (and removal) of pre‐cancerous adenomas at colonoscopy is imperative. GI Genius™ (Medtronic Ltd) is a computer‐aided detection system that integrates with existing endoscopy systems and improves adenoma detection during colonoscopy. COLO‐DETECT aims to assess the clinical and cost effectiveness of GI Genius™ in UK routine colonoscopy practice. Methods and analysis Participants will be recruited from patients attending for colonoscopy at National Health Service sites in England, for clinical symptoms, surveillance or within the national Bowel Cancer Screening Programme. Randomization will involve a 1:1 allocation ratio (GI Genius™‐assisted colonoscopy:standard colonoscopy) and will be stratified by age category (